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Abstract 
Post-Traumatic Stress Disorder (PTSD) has been associated with changes in psychophysiological and 
neuroendocrinal parameters. Cognitive Behavioral Therapy (CBT) is considered the treatment of 
choice for PTSD and is able to regularize altered neurobiological parameters; however, little is known 
about its effects on these parameters when measured during the therapeutic process. This pilot study 
aimed to evaluate the impact of CBT on cortisol and cardiac parameters measured at rest during the 
treatment of PTSD with comorbid major depression. 14 patients were randomized to four months of 
CBT or a waiting list. As expected, the experimental group had a greater reduction in PTSD symptoms 
and a large effect size. There was a reduction in the low frequency component of heart rate variability, 
which achieved borderline statistical significance and a large effect size. Salivary cortisol tended to 
track the progress of therapy, rising in the period of exposure and decreasing by the end of treatment. 
Despite the small sample size, this study opens the way for further research into the impact of CBT on 
the different biological markers of PTSD during the therapeutic process. This can hopefully help to 
optimize and personalize therapeutic studies while providing clues about modifications in bio 
behavioral pathological manifestations. 
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1. Introduction 
Post-traumatic stress disorder, which is usually associated with a significant impairment of social, work 
and family life, is a chronic debilitating reaction to a traumatic situation. This reaction involves 
symptoms of reexperience, avoidance, negative changes in cognition and mood and autonomic 
hyperarousal (American Psychiatric Association, 2013). Fear processing neural, psychophysiological 
and behavioral markers (Shvil, 2003) have begun to be investigated in an effort to enable more accurate 
diagnosis and prognosis, and provide more effective treatments (Singh & Rose, 2009). 
Cardiac autonomic dysregulation is considered a psychophysiological marker of PTSD. This disruption 
can be studied by extracting the sympathetic and parasympathetic components of Heart Rate Variability 
(HRV) (Berntson et al., 2007). Several studies have shown that a reduction in parasympathetic 
components is associated with poor general health and increased cardiovascular morbidity and 
mortality (Tsuji et al., 1996; Dekker et al., 2000; Thayer & Lane, 2007; Nunan et al., 2010). In addition, 
reduced cardiac parasympathetic function can follow or precede the development of various risk factors, 
meaning that high parasympathetic activity is a predictor of good health and good autonomic and 
emotional regulation (Pumprla et al., 2002; Thayer & Lane, 2007; Vanderlei et al., 2009). The most 
prominent cardiovascular alterations in PTSD include increased heart rate during the presentation of 
stimuli conditioned to trauma (Peri et al., 2000), increased resting heart rate (Orr, Metzger, & Pitman, 
2000), slower heart recovery compared to non-traumatized subjects (Wessa & Florr, 2007; Norte et al., 
2013), and decreased heart rate variability when compared to subjects who have been through a 
traumatic event, but did not develop PTSD (Norte et al., 2013). 
The role of cortisol in PTSD has been investigated because it is a hormone activated in response to 
stress. Its secretion is mainly controlled by the Hypothalamic-Pituitary-Adrenal (HPA) axis, and 
prolonged activation of the HPA axis has been associated with numerous deleterious effects including 
obesity, impaired immunity, atherosclerosis, and brain nerve cells atrophy (McEwen, 2003). Research 
involving PTSD and the HPA system has generated inconsistent results (Morris et al., 2012; Meewisse 
et al., 2007), possibly due to the variety of methods used and the differences between the investigated 
samples. For example, PTSD and major depression, which has a comorbidity index of 37% (Breslau, 
Davis, Andreski, & Peterson, 1991), seems to have a different impact on cortisol activation 
(Kendall-Tackett, 2000). A meta-analysis on the subject evaluated 47 studies and concluded that 
baseline morning cortisol levels are lower in patients with PTSD or PTSD comorbid with depression 
when these groups are compared to subjects who suffered trauma. However, afternoon or evening 
cortisol levels are lower in PTSD patients compared to non-traumatized subjects, but when there is 
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comorbid depression, cortisol levels are higher (Morris et al., 2012). 
Research into psychophysiological markers leads to a better understanding of the benefits of existing 
treatments. It is known that Cognitive-Behavioral Therapy (CBT) has documented efficacy in the 
treatment of PTSD, significantly reducing psychological symptoms (Bisson, 2007); however, little is 
known about its impact on biological parameters. In a recent meta-analysis, a reduction in heart rate 
caused by cognitive behavioral protocols administered in patients with PTSD was found (Gonçalves et 
al., 2015) but no studies were found when biological parameters were assessed at rest rather than 
during symptom evocation. The objective of this study was, therefore, to evaluate possible cardiac and 
neuroendocrine changes in PTSD patients during treatment with CBT when they are measured at rest. 
 
2. Materials and Methods 
2.1 Sample 
14 adults of both genders took part in the study. They were recruited through the media (newspapers, 
magazines, television and radio) and by the dissemination of information about the treatment to health 
professionals. Only patients over 18 years old diagnosed with the full criteria for PTSD, according to 
the Structured Clinical Interview for DSM-IV (SCID), were included in the study. Pharmacological 
treatment was allowed during the study. 
Excluded subjects were those in parallel psychotherapeutic treatment, who met diagnostic criteria for 
antisocial personality disorder or borderline personality disorder, were addicted to alcohol or drugs, had 
serious brain conditions, were pregnant or had primary psychosis. The study was approved by the 
Ethics Committee of the Institute of Psychiatry, Federal University of Rio de Janeiro under the CAAE 
number 0051.0.249.000-11, and covered the terms of informed consent, questionnaires, treatment 
protocols and psychophysiological evaluation. Participation in this study was subject to the participants 
signing a document giving their free and informed consent. 
2.2 Procedures 
Potential participants were assessed using the SCID by a psychiatrist. Participants who met the 
inclusion criteria were randomized to active treatment (experimental group) or waiting list (control 
group). Randomization was performed by sequence numbers randomly generated by software. Both 
groups had monthly psychometric and psychophysiological evaluations, from one week before the 
beginning of the therapy/waiting period until the end of therapy/waiting time (pre to month 4, totaling 5 
evaluations). The experimental group had an extra evaluation, one month after the end of treatment 
(follow up). After the waiting period (four months), the same treatment was offered to the control group 
participants. Figure 1 describes the procedures. 
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Figure 1. Flow Diagram for the Procedure 
 
After participants signed the free and informed consent form, the first endocrine and cardiac 
evaluations were conducted, followed by the completion of the psychometric questionnaire. Each stage 
of data collection was conducted as follows: 
The patient was asked not to eat anything for at least an hour prior to their appointment. They were 
allowed to drink water during this period. After at least five minutes of sitting without any activity, the 
following steps were taken: (1) endocrine evaluation; (2) cardiac evaluation; (3) general questions: 
participants responded to four questions: were there any stressful event during that week; what time did 
he/she go to sleep the day before and wake up on the day of the experiment; which medications were 
taken on the day of the experiment; and, for women, was she in the menstrual period; (4) psychometric 
evaluation. 
2.2.1 Endocrine Evaluation 
Salivary cortisol is considered to be a reliable and valid measure of unbound (“free”) cortisol 
concentration in the plasma. In each evaluation, one unstimulated saliva sample was collected during 
the experimental session by the use of a cotton swab. Samples were collected for 1 min at rest. Saliva 
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was extracted from the cotton swab by centrifugation at 5000 rpm for 10 min. Cortisol concentrations 
were determined by radioimmunoassay using a commercial kit (DIAMETRA). 
2.2.2 Cardiac Evaluation 
Accurate analysis of HRV can be performed by different methods: in the time domain, the Root Mean 
Square of Successive Differences (RMSSD) indicates parasympathetic activity; in the frequency 
domain, High Frequency (HF) is also indicative of vagal influence on the heart, while Low Frequency 
(LF) is indicative of the vagal and sympathetic components, predominantly sympathetic. For the 
present study, a computer running Acknowledge (BIOPAC Systems Inc.) software controlled the data 
acquisition of the electrocardiographic parameters. Electrocardiographic recordings were collected at a 
sampling frequency of 1000 Hz and at lead II. An off-line peak detection algorithm (derivative plus 
threshold) was used to estimate fiducial R-wave points, after which the series was screened by hand 
and corrected for artefacts. Successive RR intervals were estimated in milliseconds. The cardiac 
parameters were extracted for 10 min and the last 5 min used for the analysis:  
 Heart Rate (HR): Correlated to increased sympathetic and decreased parasympathetic 
activity;  
 High Frequency (HF), from 0.15 to 0.4 Hz: a marker of parasympathetic activity;  
 Low Frequency (LF), from 0.04 to 0.15 Hz: possibly correlated to sympathetic and 
parasympathetic activity or to baroreflex sensibility;  
 Root Mean Square of Successive R-R interval Differences (RMSSD): a marker of 
parasympathetic activity. 
The data processing followed the recommendations of the Task Force of the European Society of 
Cardiology and the North American Society of Pacing Electrophysiology. The Matlab software 
(KARDIA) was used to analyse cardiac parameters. 
2.2.3 Psychometric Evaluation 
The Post Traumatic Stress Disorder Checklist-Civilian Version questionnaire (PCL-C) is a 
self-administered instrument for assessing symptoms of PTSD. The Brazilian version consists of 17 
items scored 1 to 5, which evaluate the diagnostic criteria described in DSM-IV (Berger et al., 2004). 
The questionnaire was completed individually by the participants. We chose to do the psychometric 
evaluation after the cardiac and neuroendocrine evaluations due to the possibility of 
psychopsysiological reactions caused by the emotional charge associated with the content of the 
questionnaire. 
2.2.4 Treatment Protocol 
The study used a treatment protocol for patients with PTSD developed by Drs Edna Foa and Barbara 
Rothbaum (Foa & Rothbaum, 1998). This protocol was adapted for the Brazilian population by 
Pedrozo (2008). One psychotherapy session and three co-therapy sessions were performed weekly, all 
of 90 minutes each, resulting in 16 main therapy sessions and 48 co-therapy sessions, over 4 months. 
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The co-therapy sessions were conducted between the psychotherapy sessions by a psychology student 
trained and supervised by a qualified psychologist with a PhD degree. The purpose of the co-therapy 
was to stimulate anxiety management techniques and to conduct in vivo exposure sessions. The 
treatment was performed as following:  
 Session 1: guided PTSD interview, psychoeducation about CBT and PTSD and anxiety 
management techniques (progressive muscle relaxation and diaphragmatic breathing or 
polarized breathing). 
 Session 2: psychoeducation about PTSD and family session aimed at giving information 
about the disorder and the therapy. 
 Session 3: cognitive restructuring of beliefs related to the traumatic event. 
 Session 4: cognitive restructuring of beliefs related to the traumatic event. 
 Session 5: psychoeducation about exposure techniques and in vivo exposure hierarchy 
worksheet. 
 Session 6: in vivo exposure and imaginary exposure (listening to a recording of the trauma 
description). 
 Session 7-16: cognitive restructuring, in vivo exposure and imaginary exposure. 
 Session 16: relapse prevention. 
2.3 Statistical Analysis 
Due to the limited number of participants, the statistical significance of differences between groups was 
obtained through the Kruskal-Wallis test. The effect size (Cohen’s d) of the mean differences between 
groups was also calculated. The results of the mean difference between assessments performed before 
and after treatment/waiting period will be presented. For evaluations carried out between these periods, 
we will present a qualitative analysis of the data. 
 
3. Results 
3.1 Baseline Evaluation 
Seven patients in the experimental group completed the treatment, while five completed the waiting 
period in the control group. All participants had comorbid major depression, no history of trauma in 
childhood and were submitted to pharmacological treatment prescribed by psychiatrists of the PTSD 
ambulatory clinic at the Federal University of Rio de Janeiro, Brazil. The socio demographic data are 
shown in Table 1: 
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Table 1. Socio-Demographic Data 
Socio demographic data Experimental group Control group 
Type of trauma     
Motor vehicle accident 2 2 
Urban violence 5 3 
Gender 
  Female 3 2 
Male 4 3 
Marital status 
  Married 2 4 
Divorced 5 1 
Years of education     
0- 9 years 0 2 
9 years 3 2 
9-12 years 1 0 
12 years 2 1 
University education 1 0 
Age     
18-30 0 0 
31-40 1 1 
41-50 4 3 
51-60 2 1 
Mean 47.43 46.8 
 
3.2 Treatment Adherence 
Two participants withdrew from the study, one from each group. The reasons for the dropouts were not 
related to adverse effects of exposure techniques. All participants who did not withdraw from the study 
completed all 16 sessions. 
3.3 Effects of Treatment 
The difference between the average pre and post-treatment/waiting period of the variables, as well as 
the p value and the effect size, are shown in Table 2. 
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Table 2. Average Differences between Pre and Post-Treatment (Total Group)/Waiting List, p 
Value and Effect Size 
Variables Delta pre-post* Delta 
pre-post* 
P value 
** 
Cohen’s d Delta pre-follow 
up 
 Experimental Control   Experimental 
PCL-C 9.71 -1.67 0.5676 0.859 10.2 
Cortisol 1.20 -1.51 0.4561 0.638 1.21 
Heart rate -3.55 -3.3 0.8501 0.015 4.69 
High Frequency 31.30 -17.81 0.3447 0.54 29.02 
Low frequency 15.09 -60.43 0.1859 0.763 58.19 
RMSSD 5.75 -2.03 0.2568 0.207 -1.69 
*Difference between before and after treatment/waiting period; ** Kruskal-Wallis test 
 
In order to know the real impact of CBT on psychophysiological parameters, we did a separate analysis 
of the patients who responded to the treatment according to the PCL-C and compared this data to the 
control group. We defined this group as the subjects that had a minimal decrease of 15 points in the 
PCL-C. These data are shown in Table 3. 
 
Table 3. Average Differences between Pre and Post-Treatment (Respondents: n=3/waiting list: 
n=5), p Value and Effect Size 
Variables Delta pre-post* Delta 
pre-post 
P value 
** 
Cohen’s d Delta pre-follow 
up 
 Experimental Control   Experimental 
PCL-C 18.5 -1.67 0.1573 1.331 10.2 
Cortisol 1.28883 -1.51 0.4795 0.575 1.21 
Heart rate -2.29874 -3.3 0.5637 0.408 4.69 
High Frequency 44.56896 -17.81 0.2482 0.578 29.02 
Low frequency 102.8095 -60.43 0.0833 2.097 58.19 
RMSSD 8.65654 -2.03 0.2482 0.323 -1.69 
*Difference between before and after treatment/waiting period; **Kruskal-Wallis test 
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3.4 Psychometric Variable 
According to the results of the PCL-C, a recording of the trauma description the experimental group 
was consistently lower at the end of the treatment, and this reduction was maintained in the follow-up 
period, one month after the end of treatment. The average decrease was 9.71 points. In the control 
group, there was also a score decrease; however, the average decrease was 6 points. 
One of the patients in the control group had a completely different pattern of response. His PCL-C 
score decreased 42 points from the beginning to the end of the waiting period. This factor is probably 
due to the effect of pharmacological treatment. If we remove this outlier patient from the analysis, the 
control group average PCL-C score increases 1.67 points. 
The comparison between the group’s average scores before and after treatment/waiting period shows 
no statistically significant (p=0.5676) effect of CBT. However, the effect size was large (Cohen’s 
d=0.859) (Figure 2). 
 
 
Figure 2. PCL-C Scores throughout the Treatment/Waiting Period 
 
The analysis of patients who responded to the treatment, shows that the result gets closer to statistical 
significance (p=0.1573) and the effect size increases (Cohen’s d=1.331). 
3.5 Cardiac Variables 
Data from seven subjects in the experimental group and four in the control group were analyzed. 
3.6 Heart Rate 
There was no statistically significant difference between the mean heart rate before and after treatment 
between groups (p=0.8501). The effect size was small (Cohen’s d=0.015). In the experimental group, 
there was a heart rate decrease only in the follow up period (Figure 3). 
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Figure 3. Heart Rate throughout the Treatment/Waiting Period 
 
An analysis of the treatment responders indicates that the difference between this subgroup and the 
control group was not significant (p=0.5637) and effect size remained small (Cohen’s d=0.408). 
3.7 High Frequency 
With respect to HF, the difference between the groups’ average scores before and after 
treatment/waiting period was not statistically significant (p=0.3447). The effect size was medium 
(Cohen’s d=0.54). There was a decrease in the experimental group at month 4 and an increase at follow 
up (Figure 4). 
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Figure 4. High Frequency throughout the Treatment/Waiting Period 
 
The analysis of patients who responded to treatment indicated that the reduction was not statistically 
significant (p=0.2482) and effect size remained medium (Cohen’s d=0.578). 
3.8 Low Frequency 
Although there was no statistically significant difference between the groups’ mean LF before and after 
treatment/waiting period (p=0.1859), there was a score decrease in this parameter in the experimental 
group. The effect size was medium (Cohen’s d=0 763) (Figure 5). 
 
 
Figure 5. Low Frequency throughout the Treatment/Waiting Period 
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The analysis of the subjects who responded to the treatment shows that the reduction achieved 
borderline statistical significance (p=0.0833) and large effect size (Cohen’s d=2.097). 
3.9 RMSSD 
Regarding RMSSD, there was no statistically significant difference between the mean score of the 
groups before and after treatment/waiting period (p=0.2568). The effect size was small (Cohen’s 
d=0.207). In the experimental group, this parasympathetic index remained decreased during treatment 
and increased further in the follow up period (Figure 6). 
 
 
Figure 6. RMSSD throughout the Treatment/Waiting Period 
 
The analysis of the subjects who responded to the treatment indicates no statistically significant 
difference when compared to the control group (p=0.2482). The effect size remained small (Cohen’s 
d=0.323). 
3.10 Endocrine Variable 
Salivary cortisol samples of five subjects in the experimental group and four in the control group were 
analyzed. Three samples were lost due a storage procedure error. The comparison between the average 
group scores before and after treatment/waiting period indicates no significant difference (p=0.4561). 
The effect size was medium (Cohen’s d=0.638).  
In the experimental group, cortisol slightly dropped in month 1, increased in month 2, decreased again 
towards month 4 and remained lower in the follow up. Cortisol level decreased 1.2 nmol/L between the 
first and last evaluation (Figure 7). 
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Figure 7. Cortisol Level throughout the Treatment/Waiting Period 
 
The analysis of the treatment responders indicates no statistically significant difference between groups 
(p=0.4795). Effect size remained medium (Cohen’s d=0.575). 
 
4. Discussion 
This study differs from the existing literature in two aspects: this is the first randomized controlled trial 
that evaluates psychometric, cardiac and endocrine parameters at rest in patients with PTSD. The 
measurement of biological parameters is usually performed during symptom evocation and, when at 
rest, it is done before symptom evocation (Dunne et al., 2012; Hinton et al., 2009; Fecteau & Nicki 
1999; Sloan et al., 2011). This study is also a pioneer in the evaluation of these parameters throughout 
the therapeutic process. As far as we are aware, previous studies involving PTSD evaluated the heart 
rate or cortisol only before and after CBT treatment (Gonçalves et al., 2015; Gerardi et al., 2010; Smyth 
et al., 2008). 
4.1 Psychometric Parameters 
The results of this pilot study suggest a reduction of PTSD symptoms in patients treated with a CBT 
protocol. Although there was no statistically significance difference between groups (p=0.5676) 
according to PCL-C, probably due to the low sample power, the effect size was large (Cohen’s 
d=0.859). Furthermore, a reduction of 18.5 points observed in the treatment responders is considered 
clinically significant. This result is in accordance with the literature that shows the efficacy of CBT in 
the treatment of PTSD in a wide range of studies (Bisson, 2007; National Collaborating Centre for 
Mental Health, 2005). Furthermore, there is a linear decrease of the PTSD symptoms from month 1 to 
month 4, which is indicative of fast and consistent therapeutic benefit, even when anxiety during the 
early stages of the exposure technique is present. 
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4.2 Neuroendocrine Parameters 
Regarding cortisol, although there was no statistically significant difference between groups (p=0.4561), 
levels of this hormone tended to follow the treatment, in that it decreased during psychoeducation, 
anxiety management and cognitive restructuring periods (month 1), increased during the early period of 
the exposure technique (month 2), decreased by the end of treatment (from month 3) and remained 
lower in the follow up. Cortisol peak may have been influenced by the exposure technique, the most 
efficacious technique in the treatment of PTSD. It might indicate that engagement in the treatment, 
which can initially increase anxiety, is important for the future decrease in cortisol level and subsequent 
improvement of symptoms. This finding is consistent with the increase in the activation of brain areas 
that initiate HPA axis activity via connection with the hypothalamus during the exposure period 
(Gottfried & Dolan, 2004; Knight et al., 2004). Increased anxiety in the early stage of treatment could 
have an impact on brain structures that release stress related hormones, which would be regularized by 
the time habituation occurs. 
In addition, the decrease in cortisol levels after treatment, which obtained medium effect size both 
when analyzing the total experimental sample (Cohen’s d=0.638) and only treatment responders 
(Cohen’s d=0.575), is consistent with the reduction of PTSD symptoms observed in PCL-C. The 
literature suggests that the levels of this hormone, when measured at rest and in the afternoon, are 
higher in patients with PTSD comorbid with major depression when compared to subjects who suffered 
trauma and did not develop PTSD (Morris et al., 2012). In this respect, the results confirm that the 
cortisol decrease caused by CBT seems to regularize previously increased levels of this hormone. 
4.3 Cardiac Parameters 
In respect of the cardiac parameters, although the literature suggests that PTSD patients have increased 
baseline heart rate and decreased heart rate variability when compared to subjects who have undergone 
trauma but did not develop PTSD (Buckley & Kaloupek, 2001; Pole, 2007; Norte et al., 2013), there 
are no studies measuring the impact of CBT on these parameters at rest. It was expected that heart rate 
would decrease in month 4 (end of treatment), but we observed this only in the follow up period. In the 
control group, this parameter remained stable, and there was an increase from the beginning to the end 
of the waiting period, following the PCL-C. Regarding the parasympathetic components of heart rate 
variability, contrary to what was expected; there was a reduction in both the HF and the RMSSD at the 
end of treatment. The HF followed the PCL-C during treatment, decreasing along with the decrease of 
symptoms, whereas the initial hypothesis was that it would increase. Regarding RMSSD, although 
there was a decrease in the last assessment, in the experimental group this parameter remained low 
throughout the treatment, which is consistent with the increased anxiety during the exposure technique. 
In the control group, as expected, this index remained more stable. We can therefore say that in the 
resting state, an increase in parasympathetic activity caused by CBT was not detected. 
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With respect to the LF, a predominantly sympathetic index, the hypothesis that it would be reduced by 
the end of treatment was confirmed. In addition, in the experimental group this parameter followed the 
decrease in the PCL-C up to month 3 and again at follow up. In the control group, there was an increase 
in LF at the end of the waiting period, which is also consistent with the psychometric variable. The 
analysis with treatment responders showed a borderline statistical significance (p=0.0833) and the 
effect size increased from medium to large (Cohen’s d=2.097). Given the sample size of this pilot study, 
we must be cautious in generalizing this result. However, replication of this finding would confirm the 
reduced activation of the sympathetic nervous system caused by CBT. The impact observed on this 
index possibly reflects the reduction of symptoms of hyperarousal observed in PTSD. 
It is possible that the parameters measured in this study would have followed the stages of treatment if 
they had been measured during symptoms evocation. This study has given us the opportunity to 
observe that in the resting state, this response does not occur in all parameters. Cortisol levels, even 
though measured at rest, rose and fell as expected throughout the therapeutic process. A larger sample 
size would possibly produce greater statistical significance to the results which at present only point in 
this direction. 
Identifying CBT’s biological mechanisms of action may encourage the creation and improvement of 
techniques that are effective in modifying pathological biobehavioral manifestations. As a result, it will 
expand the ability to personalize treatment, taking into account different subtypes of the disorder, and 
reducing the therapeutic time required to overcome maladaptive behaviors. 
 
5. Limitations 
The main limitation of this study is the small sample size, which increases the risk of type 2 error. 
Another limitation concerns the use of pharmacological treatments during the protocol/waiting period 
and the absence of a blind evaluator. In addition, we did not use the original and most widely-used 
questionnaire for the evaluation of symptoms, the Clinician Administered PTSD Scale (CAPS). 
 
6. Conclusions 
The results of this pilot study showed no changes in cardiac and endocrine parameters caused by CBT, 
when measured in a resting state. However, this is a pilot study with a small sample, which leads to the 
possibility of false-negative results. In regard to neurobiological parameters, cortisol levels tended to 
parallel the therapeutic process, rising during the early period of exposure and decreasing in the 
psychoeducation, anxiety management and cognitive restructuring phases. CBT impact was observed in 
the LF index of heart rate variability, which may be related to the reduction of autonomic arousal 
symptoms caused by CBT. The other cardiovascular parameters, on the other hand, when measured in a 
resting state, did not follow the impact of CBT, suggesting that only cardiac reactivity measured during 
symptom evocation responds to the impact caused by the treatment, or that the sample was too small to 
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achieve statistical significance. 
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